|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.6 HKD | 0.00% |
|
+9.20% | +5.62% |
| Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
| Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
EXCLUSIVE-WHO DOCUMENT SAYS APPROVAL OF CHINESE VACCINES FROM SINOPHARM, SINOVAC POSSIBLE IN MARCH AT THE EARLIEST
| 1st Jan change | Capi. | |
|---|---|---|
| +5.62% | 8.61B | |
| +15.65% | 70.36B | |
| +2.72% | 25.18B | |
| +6.10% | 8.14B | |
| -21.85% | 7.83B | |
| +0.73% | 4.56B | |
| +17.40% | 4.32B | |
| -0.14% | 4.06B | |
| -2.34% | 3.87B | |
| +21.03% | 3.61B |
SINOPHARM GROUP CO. LTD. 
